X0306
4
2018-08-01
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001706863
RAY DEBANJAN
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2018-08-01
4
M
0
2710
1.2599
A
8638
D
Common Stock
2018-08-01
4
M
0
290
1.4489
A
8928
D
Common Stock
2018-08-01
4
S
0
3000
26.05
D
5928
D
Stock Option (Right to Buy)
1.2599
2018-08-01
4
M
0
2710
0.00
A
2023-12-10
Common Stock
2710
0
D
Stock Option (Right to Buy)
1.4489
2018-08-01
4
M
0
290
0.00
A
2024-02-27
Common Stock
290
19220
D
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
100% of the shares subject to the option are fully vested and exercisable.
/s/ Debanjan Ray
2018-08-02